| Ytd | 45.23% | |
| 1y | 253.89% |
| Open | 2.52 | Prev Close | 2.41 | Low | 2.35 | High | 2.52 | Mkt Cap | 317.84M |
| Vol | 279.53K | Avg Vol | 2.38M | EPS | -0.29 | P/E | -8.31 | Forward P/E | -2.44 |
| Beta | 0.18 | Short Ratio | 3.05 | Inst. Own | 56.41% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 2.51 | 200-d Avg | 2.01 | 1yr Est | 3.26 |
Kevin Norrett, a proven leader in advancing corporate strategy through value-creating transactions,
U.S. stock futures mixed, Nasdaq 100 falls 200 pts. Rivian (RIVN) drops after public offering announ
uniQure reported early seizure reductions in an AMT-260 epilepsy study, with no treatment-related se
Ovid Therapeutics (NASDAQ:OVID) reported quarterly losses of $(0.12) per share which missed the anal
Wedbush analyst Laura Chico reiterates Ovid Therapeutics (NASDAQ:OVID) with a Outperform and main
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Ovid Therapeutics (NASDAQ:OVID) with
During Wednesday's trading, 517 companies set new 52-week lows.
On Tuesday, 838 companies hit new 52-week lows.
On Monday, 149 companies reached new 52-week lows.
Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 19, 2018